Streetbeat News

Analyst Ratings

MET

Goldman Sachs analyst Alex Scott has upgraded MetLife (NYSE:MET) from Neutral to Buy and set a price target of $80.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 11:38 am

CMS

Seaport Global analyst Angie Storozynski has downgraded CMS Energy (NYSE:CMS) from Buy to Neutral, indicating a change in the firm's outlook on the stock.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 11:38 am

BRO

Goldman Sachs analyst Robert Cox has upgraded Brown & Brown (NYSE:BRO) from Neutral to Buy, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 11:37 am

CCK

COP

META

MSFT

RMBS

Wall Street's most accurate analysts have made recent stock picks with significant upside potential. Scott Devitt from Wedbush maintains an Outperform rating on Meta Platforms (META) with a price target increase to $420, seeing a 19% upside. John Freeman of Raymond James keeps a Strong Buy on ConocoPhillips (COP) with a reduced target of $140, indicating a 21% upside. John Roberts from Mizuho continues a Buy rating on Crown Holdings (CCK) with a target raised to $105, a 14% upside. Kevin Cassidy of Rosenblatt reiterates a Buy on Rambus (RMBS) with an $85 target, suggesting a 25% surge. Daniel Ives of Wedbush maintains an Outperform on Microsoft (MSFT) with a target upped to $450, a 20% upside. Meta Platforms is launching a fact-checking program, ConocoPhillips is advancing the Willow project, Crown Holdings posted in-line Q3 earnings, Rambus announced a new DDR5 RCD, and Microsoft introduced an AI-driven app for Android.

Portfolio Pulse from Avi Kapoor

January 08, 2024 | 11:33 am

AAL

Morgan Stanley analyst Ravi Shanker has upgraded American Airlines Group (AAL) from Equal-Weight to Overweight and set a price target of $20.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 11:33 am

ANGO

HC Wainwright & Co. analyst Yi Chen has maintained a Buy rating on AngioDynamics (NASDAQ:ANGO) but has reduced the price target from $20 to $18.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 11:33 am

BEN

Wells Fargo analyst Finian O'Shea has upgraded Franklin Resources (NYSE:BEN) from Underweight to Equal-Weight and increased the price target from $24 to $30.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 11:31 am

NGNE

HC Wainwright & Co. analyst Mitchell Kapoor has initiated coverage on Neurogene (NASDAQ:NGNE) with a Buy rating and set a price target of $45.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 11:31 am

LBPH

HC Wainwright & Co. analyst Patrick Trucchio has reaffirmed a Buy rating on Longboard Pharmaceuticals (NASDAQ:LBPH) and increased the price target from $25 to $60.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 11:29 am

GOSS

HC Wainwright & Co. analyst Patrick Trucchio has maintained a Buy rating on Gossamer Bio (NASDAQ:GOSS) and increased the price target from $5 to $10.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 11:27 am